bI, bII, and g are designated as classical PKC isoforms, Treatment of lymphokine-activated killer (LAK) which are Ca 2/ dependent and activated by diacylglyccells with phorbol ester (PMA) caused the downmodu-erol (DAG) and phorbol 12-myristate 13-acetate (PMA). lation of LAK activity concomitantly with the inhibi-There are also Ca 2/ -independent isoforms, like PKC d, tion of serine esterase (SE) release, which has been e, u, which can be activated by DAG or PMA. The third shown as a marker for perforin-dependent cell-medi-atypical PKC isoforms are PKC z and l, which are ated cytotoxicity. The reduction of perforin-dependent insensitive to Ca 2/ and DAG/PMA.
ity. However, little has been clarified about the role of PKC isoforms in both perforin and Fas-mediated cytotoxicity (15) (16) (17) .
In this paper, we investigated the role of PMA-sensiIt has been well demonstrated that protein kinase tive PKC isoforms in both perforin and Fas-dependent C (PKC) is one of the important signaling molecules cytotoxicity using short-term cultured LAK cells generinvolved in a variety of immune responses such as T ated from normal and perforin-knock out (PKO) mice. cell activation, cytokine production and regulation of Our results clearly demonstrated that PMA-sensitive cell-mediated cytotoxicity (1-5). PKC consists of several PKC isoforms were involved in perforin-dependent different isoforms with distinct properties (6). PKC a, LAK-mediated cytotoxicity but not in Fas-dependent LAK cytotoxicity.
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MATERIALS AND METHODS
tivated killer; DAG, diacylglycerol; PMA, phorbol 12-myristate 13-acetate; SE, serine esterase; CTL, cytotoxic T lymphocytes; PKO, perforin-knock out; PKO-LAK, LAK cells generated from PKO mouse Mice. C57BL/6 mice were purchased from Charles River Japan Inc. (Yokohama, Japan). C57BL/6 perforin-knock out (PKO) mice spleen cells.
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FIG. 1.
The inhibition of LAK cell-mediated cytotoxicity by PMA and PKC inhibitor. (A) LAK cells generated from C57BL/6 mice were incubated with (closed bars) or without (hatched bars) PMA (20 ng/ml) for 24 hr. Then, their cytotoxicity against various target cells was measured by 4 hr-51 Cr-release assay. (B) SE release of LAK cells, which were pretreated with none or PMA for 24 hrs, was induced by stimulation with (closed bar) or without (hatched bar) PMA (20 ng/ml) plus A23187 (500 ng/ml) for 2 hrs. SE-release (%) was calculated as described under Materials and Methods. (C) LAK cells were incubated with PMA (24 hrs) or PKC-inhibitor, GF 109203X (5 mM; 30 min) and their cytotoxicity and SE-release were measured. As control, LAK cells were incubated alone (None). The bars represent mean { SE of triplicate samples.
were purchased from Taconic (NY12526) (18). All animals were fecells. For investigating Fas-mediated cytotoxicity, L5178Y cells transfected with mouse Fas gene (A1 cells) or mutated Fas gene (F10 male and used at 5-8 weeks of age. cells) were kindly donated from Dr. Shin Yonehara (Kyoto UniverThe generation of LAK cells. LAK cells were generated from sity, Kyoto, Japan) (19). spleen cells obtained from C57BL/6 or C57BL/6 PKO mice by culturing with IL-2 (2000 U/ml, kind gift of Shionogi Pharmaceutical InstiSerine esterase (SE) release assay. SE release was determined by tute Co., Ltd., Osaka, Japan) for 4 days at 37ЊC using 12 well culture the method described in the previous paper (5, 13). Briefly, cells (2 plates at the cell density of 5 1 10 6 /well (13).
1 10 5 /ml) were cultured with PMA (20 ng/ml) plus A23187 (500 ng/ ml) for 1-2 hrs in a plastic tube. An 100 ml of culture supernatant Cytotoxicity assay. The cytotoxicity of killer cells was measured was trasferred to 96 well flat-bottomed plate and the SE activity was by 4 hr 51 Cr-release assay as described previously (5 10 5 ) with 0.1% Triton X-100 (500 ml). Specific SE release (%) was equal to: (SE release for LAK cells cultured with PMA plus A23187 -spontaneous SE release) / Total contents of SE activity in LAK cells 1 100. 6   ) were cultured with or without PMA (20 ng/ml) for 24 hrs, lysed with 5 ml of TNE buffer {150 mM NaCl, 1 mM EDTA, 1% NP-40, 1 mM PMSF, 1 mM aprotinin in 10 mM Tris-HCl buffer (pH 7.5)} and separated on 10% SDS-PAGE. The proteins were transferred to polyvinylidene difluoride (PVDF), and immunoblot analyses were performed using mAbs specific to PKC-a, g, e, u, l, z, which were purchased from Transduction Laboratories Inc. (Lexington, KY). In some experiments, GF 109203X (Sigma, St Louis, MO) (20) was used as a specific inhibitor of PKC at the concentration of 5 mM.
Detection of PKC isoforms by immunoblotting. LAK cells (10

RESULTS AND DISCUSSION
LAK cells, which were induced from C57BL/6 mice by culturing with 2000 U/ml IL-2 for 4 days, showed a strong cytotoxicity against a variety of tumor cells. greatly inhibited by 24 hr-PMA-treatment (Fig. 1B) . Such downmodulation of both LAK activity and SE-PKC isoforms, PMA-sensitive PKC isoforms appeared to be essential for the induction of perforin-depedent release was also induced by PKC inhibitor, GF 109203X (Fig. 1C ) though its inhibitory effect was LAK cell-mediated cytotoxicity.
It is now well accepted that two distinct mechanisms lower than that induced by PMA. Therefore, PMA-induced downmodulation of LAK activity was considered are involved in cell-mediated cytotoxicity (15) (16) (17) 21) .
One is perforin-dependent cytotoxicity and the other is to be derived from the inactivation of PMA-sensitive PKC isoforms.
Fas-dependent cytotoxicity. To determine the role of PMA-sensitive PKC isoforms in Fas-dependent cytoIt has been demonstrated that long-term PMA treatment of the cells resulted in the inhibition of PKC activ-toxicity, we next examined the effect of PMA-treatment on both perforin-dependent and Fas-dependent LAK ity (desensitization) (5, 10-13). Recently, it was further clarified that the desensitization of PKC activity was activity. As shown in Fig. 3 , LAK cells totally lost their cytotoxicity against Fas 0 L5178Y tumor cells after due to the downmodulation of PMA-sensitive PKC isoforms (7-9, 12). As shown in Fig. 2 , immunoblotting treatment with PMA for 24 hrs (Fig. 3A) . However, the LAK activity against Fas / A1 cells, which were L5178Y study clearly demonstrated that PMA-treatment of LAK cells caused the disappearance of PKCa, g, e, and cells transfected with mouse Fas-gene, was not inhibited by PMA-treatment (Fig. 3B) . In contrast, LAK acu (Fig 2, A-D) , which are defined as a PMA-sensitive PKC isoform proteins (7-9). However, PMA-insensitive tivity against mutated Fas / F10 cells, which were L5178Y cells transfected with mutated mouse Fas-PKC isoforms such as PKC l, z in LAK cells was not affected by PMA-treatment ( Fig. 2E and F) . Thus, judg-gene, was inhibited by PMA-treatment (Fig. 3C) . Thus, it was strongly suggested that PMA-sensitive PKC isoing from the evidence that PMA-treatment of LAK cells downmodulated both SE release, LAK activity and forms appeared not to be necessary for Fas-mediated of Education, Science and Culture of Japan, a Research Grant from LAK cell-mediated cytotoxicity. To demonstrate this the Ministry of Health and Welfare and a Grant-in-Aid for IL-12 hypothesis, we finally examined the effect of PMA-project from Tokai University School of Medicine. treatment on the cytotoxicity mediated by PKO mousederived LAK cells (Fig.3D) . The LAK cells derived from REFERENCES C57BL/6 PKO mice (PKO-LAK) revealed no significant cytotoxicity against LAK-sensitive Fas with PMA revealed an enhanced cytotoxicity against 17. Kä gi, D., Vignaux, F., Ledermann, B., Bü rki, K., Depraetere, V., Fas 0 target cells by crosslinking with anti-CD3 mAb
